Answers are grounded in this paper and cite their sources.
To the Editor: We have read with much interest the report by Meawad et al1 on a case of a primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) mimicking ALK-1 negative anaplastic large cell lymphoma (ALCL). It caught our attention that the tumor cells showed many features which are characteristic of ALCL such as hallmark cells, anaplasia, pleomorphism, and CD30 positivity. Lack of ALK expression is also typical of primary cutaneous ALCL.2 Nevertheless, the authors made the diagnosis of PCGD-TCL based on the panniculitic pattern, the rimming, and mainly on the immunostaining for T-cell receptor (TCR)-delta. We would like to remark that prominent involvement of the subcutaneous fat is identified in some cases of primary cutaneous ALCL.3 We are also aware that, to the best of our knowledge, no cases of gamma-delta ALCL have been published so far, although Pulitzer et al4 reported one case of a “CD30 lymphoproliferative disorder borderline” which showed an intense and diffuse TCR delta expression. In addition, there are cases of gamma-delta lymphomatoid papulosis, which is another CD30+ lymphoproliferative disorder closely related to primary cutaneous ALCL.5 The current case was negative for CD4 and CD8. This is not a handicap for the diagnosis of primary cutaneous ALCL, because only one‐third of cases are positive for CD4, and negativity for CD4 and CD8 is seen in almost half of the cases.3 In addition, most of PCGD-TCL are CD30 negative, and when positive, they usually show low-medium expression of the marker.6 Primary cutaneous ALCL usually presents with eosinophils,3 which are rarely seen in PCGD-TCL. Although it is not sharply appreciated, Figure 2b seems to show some eosinophils accompanying the tumoral cells. Regarding the clinical presentation, lesions of PCGD-TCL often are ulcerated, involvement of mucosae is frequent, B symptoms occur in most cases, and lactate dehydrogenase is normally elevated. In addition, involvement of soft tissue and lymph nodes by the PCGD-TCL are usually present at the time of diagnosis.7 None of these features were reported in the case report of the authors. Multiple lesions are not uncommon in CD30 positive lymphomas: Although most frequent in lymphomatoid papulosis, such presentation has also been described in some cases of primary cutaneous ALCL,3 so much so that the latter can sometimes clinically mimic the former. Cases of PCGD-TCL have been described after treatment with etanercept, but this drug has also been associated with primary cutaneous ALCL.8 We believe that the current case would better fit into the diagnosis of TCR delta positive primary cutaneous ALCL. Therefore, we agree that this case is extraordinary, as in our opinion, it represents the first well-documented case of gamma-delta primary cutaneous ALCL. The good response to treatment is also more in consonance with primary cutaneous ALCL. However, long-term follow-up will probably give us more reliable information on the prognosis of this lymphoma, and we believe that the entire scientific community would be grateful if the authors could keep us informed.
No takes yet. Share an insight, caveat, or question.
Taibo et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: